The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

A national survey shows that most Americans still support MMR vaccination for children, but public understanding of measles ...

The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

In a letter sent Tuesday, Sen. Lisa Blunt Rochester (D-Del.) demanded that health secretary Robert Kennedy clarify whether ...

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.